(Q45096831)

9 December 2017

title

Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease (English)

1 reference

9 December 2017

1 reference

Sunanda Kane

1

1 reference

9 December 2017

Stanley M Cohen

series ordinal

2

1 reference

9 December 2017

John Hart

series ordinal

3

1 reference

9 December 2017

publication date

1 September 2004

1 reference

Inflammatory Bowel Diseases

9 December 2017

published in

1 reference

9 December 2017

volume

10

1 reference

9 December 2017

issue

5

1 reference

9 December 2017

page(s)

652-654

1 reference

6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.

9 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00023

6-Thioguanine treatment of psoriasis: experience in 81 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00023

6-Thioguanine therapy for psoriasis causing toxic hepatic venoocclusive disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00023

6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00023

6-thioguanine can cause serious liver injury in inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00054725-200409000-00023

10.1097/00054725-200409000-00023

21 January 2018

Identifiers

DOI

1 reference

9 December 2017

1 reference